Literature DB >> 4208531

Suppression of growth of Ehrlich ascites tumor cells in mice by trehalose-6,6'-dimycolate (cord factor) and BCG.

E Yarkoni, L Wang, A Bekierkunst.   

Abstract

Growth of Ehrlich ascites tumor cells in mice pretreated with cord factor was compared to growth of the tumor cells after pretreatment with Calmette-Guérin bacilli. Growth of Ehrlich ascites cells was strongly inhibited in the peritoneal cavities of mice pretreated with 80 mug of cord factor. The median survival time of the animals was prolonged (70 versus 17 days), and 40% of the mice survived more than 90 days. Tumor suppression was still detectable 36 days after administration of cord factor. The effect of cord factor was local. Comparable results were obtained with living or killed Calmette-Guérin bacilli. The results are discussed.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4208531      PMCID: PMC414920          DOI: 10.1128/iai.9.6.977-984.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Tumor-graft rejection in syngeneic guinea pigs: evidence for a two-step mechanism.

Authors:  B Zbar; H T Wepsic; T Borsos; H J Rapp
Journal:  J Natl Cancer Inst       Date:  1970-02       Impact factor: 13.506

2.  AN ACUTE PULMONARY GRANULOMATOUS RESPONSE IN MICE PRODUCED BY MYCOBACTERIAL CELLS AND ITS RELATION TO INCREASED RESISTANCE AND INCREASED SUSCEPTIBILITY TO EXPERIMENTAL TUBERCULOUS INFECTION.

Authors:  G P YOUMANS; A S YOUMANS
Journal:  J Infect Dis       Date:  1964-04       Impact factor: 5.226

3.  Studies on the mechanism of non-specific resistance to Brucella induced in mice by vaccination with BCG.

Authors:  D SULITZEANU; A BEKIERKUNST; L GROTO; J LOEBEL
Journal:  Immunology       Date:  1962-01       Impact factor: 7.397

4.  Supression of growth of Ehrlich ascites tumor cells in mice pretreated with synthetic analogs of trehalose-6,6-dimycolate (cord factor).

Authors:  E Yarkoni; A Bekierkunst; J Asselineau; R Toubiana; M J Toubiana; E Lederer
Journal:  J Natl Cancer Inst       Date:  1973-08       Impact factor: 13.506

5.  [Non specific active immunotherapy by B.C.G. in virus induced leukemia in E male G2 mice in isogenic receiptients].

Authors:  J L Amiel
Journal:  Rev Fr Etud Clin Biol       Date:  1967-11

6.  Recent studies on acquired immunity in tuberculosis.

Authors:  G P Youmans; A S Youmans
Journal:  Curr Top Microbiol Immunol       Date:  1969       Impact factor: 4.291

7.  Immune response to sheep red blood cells in mice pretreated with mycobacterial fractions.

Authors:  A Bekierkunst; E Yarkoni; I Flechner; S Morecki; E Vilkas; E Lederer
Journal:  Infect Immun       Date:  1971-09       Impact factor: 3.441

Review 8.  Immunological factors which influence response to immunotherapy in malignant melanoma.

Authors:  D Morton; F R Eilber; R A Malmgren; W C Wood
Journal:  Surgery       Date:  1970-07       Impact factor: 3.982

9.  Cellular reaction in the footpad and draining lymph nodes of mice induced by mycobacterial fractions and BCG bacilli.

Authors:  A Bekierkunst; I S Levij; E Yarkoni; E Vilkas; E Lederer
Journal:  Infect Immun       Date:  1971-09       Impact factor: 3.441

10.  Suppression of urethan-induced lung adenomas in mice treated with trehalose-6,6-dimycolate (cord factor) and living bacillus Calmette Guérin.

Authors:  A Bekierkunst; I S Levij; E Yarkoni
Journal:  Science       Date:  1971-12-17       Impact factor: 47.728

View more
  10 in total

Review 1.  Cell walls of Mycobacteria and related organisms; chemistry and immunostimulant properties.

Authors:  E Lederer; A Adam; R Ciorbaru; J F Petit; J Wietzerbin
Journal:  Mol Cell Biochem       Date:  1975-05-30       Impact factor: 3.396

2.  Effect of Mycobacterium bovis and Mycobacterium tuberculosis on the take and survival of chickens with transplanted MC-29 hepatoma.

Authors:  I Földes; A Gyuris
Journal:  Experientia       Date:  1975-07-15

3.  MSU Crystals Enhance TDB-Mediated Inflammatory Macrophage IL-1β Secretion.

Authors:  Kanu Wahi; Kristel Kodar; Melanie J McConnell; Jacquie L Harper; Mattie S M Timmer; Bridget L Stocker
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

4.  Stimulation of lymphocyte proliferation by killed mycobacteria and other bacterial species.

Authors:  A Bekierkunst
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

5.  Failure of trehalose-6,6'-dimycolate (P3 or cord factor) to enhance endotoxin lethality in mice.

Authors:  E Yarkoni; M S Meltzer; H J Rapp
Journal:  Infect Immun       Date:  1976-12       Impact factor: 3.441

6.  Nonspecific resistance against infection with Salmonella typhi and Salmonella typhimurium induced in mice by cord factor (trehalose-6,6'-dimycolate) and its analogues.

Authors:  E Yarkoni; A Bekierkunst
Journal:  Infect Immun       Date:  1976-11       Impact factor: 3.441

7.  Stimulation of macrophages by cord factor and by heat-killed and living BCG.

Authors:  E Yarkoni; L Wang; A Bekierkunst
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

8.  Parallel antitumor, granuloma-forming and tumor-necrosis-factor-priming activities of mycoloyl glycolipids from Nocardia rubra that differ in carbohydrate moiety: structure-activity relationships.

Authors:  Y Natsuhara; S Oka; K Kaneda; Y Kato; I Yano
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

9.  Immunotherapy of Cancer with Nonliving BCG and Fractions Derived from Mycobacteria: Role of Cord Factor (Trehalose-6, 6'-Dimycolate) in Tumor Regression.

Authors:  A Bekierkunst; L Wang; R Toubiana; E Lederer
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441

10.  The Mincle ligand trehalose dibehenate differentially modulates M1-like and M2-like macrophage phenotype and function via Syk signaling.

Authors:  Kristel Kodar; Jacquie L Harper; Melanie J McConnell; Mattie S M Timmer; Bridget L Stocker
Journal:  Immun Inflamm Dis       Date:  2017-07-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.